Home › ORCHPHARMA › Filing
🔔 Get instant alerts when ORCHPHARMA files quarterly results on BSE Start free trial →
Orchid Pharma Limited (ORCHPHARMA)

Updates

Filed: 16 Nov 2026, 19:25 IST Exchange: NSE Category: Regulatory Compliance — Listing Regulation Fine
Board noted Rs 2,000 fine plus GST for one-day delay in FY26 Annual Report filing under SEBI Reg 34. - Fine paid to NSE and BSE - Board advised management to strengthen compliance monitoring - Delay was in dispatch date to shareholders - Company committed to avoid future delays - Fine details and payment instructions received from NSE
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ORCHPHARMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ORCHPHARMA to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Orchid Pharma Limited

Important. The summary above is generated automatically from Orchid Pharma Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.